Sign up to save your podcasts
Or
Share Claudin 18.2 - a SPOTLIGHT on Zolbetuximab - Part 2 of 2
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Claudin 18.2 - a SPOTLIGHT on Zolbetuximab - Part 2 of 2
In this episode of MedOncNow, Dr. Christine Brezden-Masley explores the clinical impact of Zolbetuximab in gastric and GEJ cancers, covering patient selection, treatment integration, and implications for systemic therapy delivery.
This is timely as ASTELLAS is funding both testing for Claudin 18.2 and access to Zolbetuximab for Gastric and GEJ cancers across Canada.
🎧 Catch up on Part 1 for insights into Claudin 18.2 testing and its role in guiding therapy decisions.
View all episodes
By OncologyEducationIn this episode of MedOncNow, Dr. Christine Brezden-Masley explores the clinical impact of Zolbetuximab in gastric and GEJ cancers, covering patient selection, treatment integration, and implications for systemic therapy delivery.
This is timely as ASTELLAS is funding both testing for Claudin 18.2 and access to Zolbetuximab for Gastric and GEJ cancers across Canada.
🎧 Catch up on Part 1 for insights into Claudin 18.2 testing and its role in guiding therapy decisions.